Literature DB >> 18165272

Locked nucleic acids can enhance the analytical performance of quantitative methylation-specific polymerase chain reaction.

Karen S Gustafson1.   

Abstract

Aberrant DNA methylation of tumor suppressor genes is a frequent epigenetic event that occurs early in tumor progression. Real-time quantitative methylation-specific polymerase chain reaction (QMSP) assays can provide accurate detection and quantitation of methylated alleles that may be potentially useful in diagnosis and risk assessment for cancer. Development of QMSP requires optimization to maximize analytical specificity and sensitivity for the detection of methylated alleles. However, in some cases challenges encountered in primer and probe design can make optimization difficult and limit assay performance. Locked nucleic acids (LNAs) demonstrate increased affinity and specificity for their cognate DNA sequences. In this proof-of-principle study, LNA residues were incorporated into primer and probe design to determine whether LNA-modified oligonucleotides could enhance the analytical performance of QMSP for IGSF4 promoter methylation in human cancer cell lines using either SYBR Green or fluorogenic probe detection methods. Use of LNA primers in QMSP with SYBR Green improved analytical specificity for methylated alleles and eliminated the formation of nonspecific products because of mispriming from unmethylated alleles. QMSP using LNA probe and primers showed an increased amplification efficiency and maximum fluorescent signal. QMSP with LNA oligonucleotides and either detection method could reliably detect five genome equivalents of methylated DNA in 1000- to 10,000-fold excess unmethylated DNA. Thus, LNA oligonucleotides can be used in QMSP optimization to enhance analytical performance.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18165272      PMCID: PMC2175541          DOI: 10.2353/jmoldx.2008.070076

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  20 in total

1.  MethylQuant: a sensitive method for quantifying methylation of specific cytosines within the genome.

Authors:  Hélène Thomassin; Clémence Kress; Thierry Grange
Journal:  Nucleic Acids Res       Date:  2004-12-02       Impact factor: 16.971

2.  Quantitative detection of methylated SOCS-1 , a tumor suppressor gene, by a modified protocol of quantitative real time methylation-specific PCR using SYBR green and its use in early gastric cancer detection.

Authors:  Michael W Y Chan; Eagle S H Chu; Ka-Fai To; Wai K Leung
Journal:  Biotechnol Lett       Date:  2004-08       Impact factor: 2.461

3.  Quantitation of GSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma.

Authors:  C Jerónimo; H Usadel; R Henrique; J Oliveira; C Lopes; W G Nelson; D Sidransky
Journal:  J Natl Cancer Inst       Date:  2001-11-21       Impact factor: 13.506

4.  MethyLight: a high-throughput assay to measure DNA methylation.

Authors:  C A Eads; K D Danenberg; K Kawakami; L B Saltz; C Blake; D Shibata; P V Danenberg; P W Laird
Journal:  Nucleic Acids Res       Date:  2000-04-15       Impact factor: 16.971

Review 5.  Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours.

Authors:  Manel Esteller; James G Herman
Journal:  J Pathol       Date:  2002-01       Impact factor: 7.996

6.  DNA methylation alterations in the pancreatic juice of patients with suspected pancreatic disease.

Authors:  Hiroyuki Matsubayashi; Marcia Canto; Norihiro Sato; Alison Klein; Tadayoshi Abe; Keishi Yamashita; Charles J Yeo; Anthony Kalloo; Ralph Hruban; Michael Goggins
Journal:  Cancer Res       Date:  2006-01-15       Impact factor: 12.701

7.  IGSF4 promoter methylation and expression silencing in human cervical cancer.

Authors:  Jianduan Li; Zhengyan Zhang; Miri Bidder; Margo C Funk; Loan Nguyen; Paul J Goodfellow; Janet S Rader
Journal:  Gynecol Oncol       Date:  2005-01       Impact factor: 5.482

Review 8.  LNA (locked nucleic acid): high-affinity targeting of complementary RNA and DNA.

Authors:  Birte Vester; Jesper Wengel
Journal:  Biochemistry       Date:  2004-10-26       Impact factor: 3.162

9.  Comparison of bisulfite modification of 5-methyldeoxycytidine and deoxycytidine residues.

Authors:  R Y Wang; C W Gehrke; M Ehrlich
Journal:  Nucleic Acids Res       Date:  1980-10-24       Impact factor: 16.971

10.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.

Authors:  J G Herman; J R Graff; S Myöhänen; B D Nelkin; S B Baylin
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

View more
  9 in total

1.  Detection of hypermethylated vimentin in urine of patients with colorectal cancer.

Authors:  Benjamin P Song; Surbhi Jain; Selena Y Lin; Quan Chen; Timothy M Block; Wei Song; Dean E Brenner; Ying-Hsiu Su
Journal:  J Mol Diagn       Date:  2012-01-16       Impact factor: 5.568

2.  Promoter methylation analysis of O6-methylguanine-DNA methyltransferase in glioblastoma: detection by locked nucleic acid based quantitative PCR using an imprinted gene (SNURF) as a reference.

Authors:  Luca Morandi; Enrico Franceschi; Dario de Biase; Gianluca Marucci; Alicia Tosoni; Mario Ermani; Annalisa Pession; Giovanni Tallini; Alba Brandes
Journal:  BMC Cancer       Date:  2010-02-18       Impact factor: 4.430

3.  Precision of pyrosequencing assay to measure LINE-1 methylation in colon cancer, normal colonic mucosa, and peripheral blood cells.

Authors:  Natsumi Irahara; Katsuhiko Nosho; Yoshifumi Baba; Kaori Shima; Neal I Lindeman; Aditi Hazra; Eva S Schernhammer; David J Hunter; Charles S Fuchs; Shuji Ogino
Journal:  J Mol Diagn       Date:  2010-01-21       Impact factor: 5.568

4.  Quantitative methylation-specific PCR for the detection of aberrant DNA methylation in liquid-based Pap tests.

Authors:  Steven L Kahn; Brigitte M Ronnett; Patti E Gravitt; Karen S Gustafson
Journal:  Cancer       Date:  2008-02-25       Impact factor: 6.860

5.  Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer-a clinical biomarker discovery and validation study.

Authors:  Sarah Østrup Jensen; Nadia Øgaard; Mai-Britt Worm Ørntoft; Mads Heilskov Rasmussen; Jesper Bertram Bramsen; Helle Kristensen; Peter Mouritzen; Mogens Rørbæk Madsen; Anders Husted Madsen; Kåre Gotschalck Sunesen; Lene Hjerrild Iversen; Søren Laurberg; Ib Jarle Christensen; Hans Jørgen Nielsen; Claus Lindbjerg Andersen
Journal:  Clin Epigenetics       Date:  2019-11-14       Impact factor: 6.551

6.  Role of DNA methylation in expression and transmission of porcine endogenous retroviruses.

Authors:  Magda Matousková; Pavel Vesely; Petr Daniel; Giada Mattiuzzo; Ralph D Hector; Linda Scobie; Yasuhiro Takeuchi; Jirí Hejnar
Journal:  J Virol       Date:  2013-08-28       Impact factor: 5.103

7.  Development of a multiplex methylation-specific PCR as candidate triage test for women with an HPV-positive cervical scrape.

Authors:  Suzanne Snellenberg; Lise M A De Strooper; Albertus T Hesselink; Chris J L M Meijer; Peter J F Snijders; Daniëlle A M Heideman; Renske D M Steenbergen
Journal:  BMC Cancer       Date:  2012-11-23       Impact factor: 4.430

8.  Epigenetic Analysis of Circulating Tumor DNA in Localized and Metastatic Prostate Cancer: Evaluation of Clinical Biomarker Potential.

Authors:  Marianne Trier Bjerre; Maibritt Nørgaard; Ole Halfdan Larsen; Sarah Østrup Jensen; Siri H Strand; Peter Østergren; Mikkel Fode; Jacob Fredsøe; Benedicte Parm Ulhøi; Martin Mørck Mortensen; Jørgen Bjerggaard Jensen; Michael Borre; Karina D Sørensen
Journal:  Cells       Date:  2020-05-31       Impact factor: 6.600

9.  Assessment of RainDrop BS-seq as a method for large-scale, targeted bisulfite sequencing.

Authors:  Dirk S Paul; Paul Guilhamon; Anna Karpathakis; Lee M Butcher; Christina Thirlwell; Andrew Feber; Stephan Beck
Journal:  Epigenetics       Date:  2014-02-11       Impact factor: 4.528

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.